Position in INCY
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$779,463
+$215,967 QoQ
Shares Held
6,876
+14.8% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#451
of 854 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UNITED CAPITAL FINANCIAL ADVISORS, LLC holds $15,880,894 across 17 Biotechnology names. INCY ranks #7 (4.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
12,438 | $6,178,327 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,651 | $1,653,004 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
4,155 | $1,250,779 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
13,677 | $1,070,498 | |
| 5 | MRNA |
Moderna, Inc.
|
13,077 | $915,782 | |
| 6 | CBUS |
Cibus, Inc.
|
576,043 | $789,178 | |
| 7 | INCY |
Incyte Corp
This page
|
6,876 | $779,463 | |
| 8 | IMMX |
Immix Biopharma, Inc.
|
70,682 | $728,731 |
All Filings in INCY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $779,463 | 6,876 | Shares | Defined | 2026-08-17 | |
| 2026-03-31 | $563,496 | 5,987 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $538,395 | 5,451 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $445,506 | 5,253 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $415,410 | 6,100 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $336,234 | 5,553 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $421,810 | 6,107 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $441,746 | 6,683 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $426,037 | 7,028 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $339,427 | 5,958 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $342,079 | 5,448 | Shares | Defined | 2024-02-14 | |
| 2023-06-30 | $270,165 | 4,340 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $439,040 | 6,075 | Shares | Defined | 2023-08-15 | |
| 2022-12-31 | $755,489 | 9,406 | Shares | Defined | 2023-02-15 | |
| 2022-09-30 | $633,146 | 9,501 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $731,743 | 9,632 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $764,417 | 9,625 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $732,605 | 9,981 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $824,190 | 11,983 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,158,974 | 13,776 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $1,179,227 | 14,510 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $1,194,409 | 13,732 | Shares | Defined | 2021-02-17 | |
| 2020-09-30 | $1,445,711 | 16,110 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $1,666,535 | 16,029 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $1,162,819 | 15,879 | Shares | Defined | 2020-08-11 | |
| No filing history on record for this holder in this stock. | ||||||